Global Cord BloodCORBF

13F holders, Q3 2025 (September 30)
2holders
0new positions
0sold out
$1.01avg. 13F price*

At the end of Q3 2025, 2 institutions reported holding Global Cord Blood Corp. (CORBF) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($13K) and Luminist Capital LLC ($165).

Company
Global Cord Blood Corp.
CUSIP
G39342103
Latest filing quarter
Q2 2026

History

Number of 13F holders

012 Q1 2024: 2Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 2Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 2Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q2 2025 → Q3 2025: 11,455 shares sold, net −11,455 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Rhumbline Advisers 0.00% Reduce -46.2% 13,362 $13K
Luminist Capital LLC 0.00% No change 165 $165

"% of holder's portfolio" is CORBF's weight in each manager's 13F, not the share of Global Cord Blood Corp. the manager owns.